STAT+: PBMs face scrutiny from all sides, and analyzing Marty Makary’s road to the FDA

This week in politics and public health: Lawmakers are working to rein in PBMs, a look at Marty Makary's record, and an interview with the CDC director.

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

Congress nears spending deal with long-awaited PBM reforms

Congress is on the edge of a deal that would reshape pharmacy benefit managers, extend telehealth access, and renew certain public health authorities.

The language of the government funding package has not been publicly released as of Monday night and could still change, but sources indicate some longtime health care policy priorities are making the cut for the year-end spending deal, Rachel Cohrs Zhang reports.

Continue to STAT+ to read the full story…